Daily Intelligence Brief
Docket Roundup: Suboxone Intake Overwhelms a Concentrated Filing Day
A 204-filing surge in Suboxone Film Products Liability (3092) made Nigh Goldenberg Raso Vaughn PLLC and Ketterer Browne & Davani LLC the lead firms in a docket day dominated by drug-product intake. Zantac Products Liability (2924) added 50 filings, all through Keller Postman LLC, a concentrated stream that does not alter the federal merits dismissal now on Eleventh Circuit appeal. At 17 filings each, Hair Relaxer Marketing, Sales Practices, and Products Liability (3060) drew six matters from Wagstaff Law Firm and three from Douglas & London, while Uber Passenger Sexual Assault (3084) split its six-case lead between Chaffin Luhana LLP and Phillips & Associates Law Firm PC. Social Media Adolescent Addiction Personal Injury Products Liability (3047) followed with 16 filings, paced by Frazer PLC’s six and Frantz Law Group APLC’s three, keeping school-district and individual platform-harm claims in the day’s top tier. See the full filing feed and firm-level breakdowns here.
Roblox Loses Bid to Cut Off Los Angeles County’s Child-Safety Case
A Los Angeles court’s Sept. 1 tentative ruling rejected Roblox’s anti-SLAPP and dismissal challenges to Los Angeles County’s child-exploitation suit, keeping the county’s public-nuisance and consumer-protection claims alive. The court treated the challenged safety representations as commercial conduct rather than insulated speech, preserving a case that targets Roblox’s marketing and child-protection practices. A Sept. 10 hearing will determine whether that ruling becomes final. For Roblox Corporation Child Sexual Exploitation and Assault (3166), the decision keeps a government plaintiff pressing product-safety and platform-representation theories that overlap with the federal litigation’s core allegations.
Camp Lejeune Track 1 Cases Move Toward Trial as Settlement Deadline Looms
Four Track 1 Camp Lejeune water-contamination cases face Sept. 10 pretrial conferences in Raleigh as court-supervised settlement negotiations continue. The scheduling orders place the first trials on a potential 30-to-45-day timetable after those conferences, creating a concrete trial-pressure point for the United States and claimants’ leadership. The court has directed the parties and settlement masters to use their best efforts toward a global resolution by Oct. 30. That sequence forces the Camp Lejeune water-contamination claims toward simultaneous valuation and trial-preparation decisions, rather than leaving settlement discussions detached from imminent merits proceedings.
Generated by LexGenius Feed. Signals sourced from PACER federal court dockets, FDA/OpenFDA adverse event database, Federal Register, PubMed, and Google News.
